{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:06:06Z","timestamp":1792800366896,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82201657"],"award-info":[{"award-number":["82201657"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["U21A20367"],"award-info":[{"award-number":["U21A20367"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100017700","name":"Henan Province Science and Technology Research Project","doi-asserted-by":"crossref","award":["23210231104"],"award-info":[{"award-number":["23210231104"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"crossref"}]},{"name":"General Program of China Postdoctoral Science Foundation","award":["General Program of China Postdoctoral Science Foundation"],"award-info":[{"award-number":["General Program of China Postdoctoral Science Foundation"]}],"id":[{"id":"https:\/\/ror.org\/0426zh255","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Henan Medical Science and Technology Research Program Project","award":["LHGJ20220310"],"award-info":[{"award-number":["LHGJ20220310"]}]},{"name":"Scientific Research and Innovation Team of The First Affiliated Hospital of Zhengzhou University","award":["ZYCXTD2023015"],"award-info":[{"award-number":["ZYCXTD2023015"]}],"id":[{"id":"https:\/\/ror.org\/056swr059","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2506204"],"award-info":[{"award-number":["2023YFC2506204"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-025-06905-1","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T09:46:55Z","timestamp":1746611215000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["White matter hyperintensities, inflammation and cognitive impairments in drug-na\u00efve first episode schizophrenia patients: a cross-sectional study"],"prefix":"10.1186","volume":"25","author":[{"given":"Yan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxia","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keju","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangkang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suying","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoduo","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"key":"6905_CR1","doi-asserted-by":"crossref","unstructured":"Leslie C. A systematic review of meta-analyses of the efficacy of oral atypical antipsychotics for the treatment of adult patients with schizophrenia. Expert Opin Pharmacother. 2011;13(11).","DOI":"10.1517\/14656566.2011.626769"},{"key":"6905_CR2","doi-asserted-by":"crossref","unstructured":"Paolo F-P et al. Treatments of negative symptoms in schizophrenia: Meta-Analysis of 168 randomized Placebo-Controlled trials. Schizophr Bull. 2014;41(4).","DOI":"10.1093\/schbul\/sbu170"},{"key":"6905_CR3","first-page":"143","volume":"125","author":"M Francesco","year":"2010","unstructured":"Francesco M, et al. Social cognition in psychosis: multidimensional structure, clinical correlates, and relationship with functional outcome. Schizophr Res. 2010;125:143\u201351.","journal-title":"Schizophr Res"},{"issue":"9","key":"6905_CR4","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1176\/appi.ajp.21070686","volume":"179","author":"G Chand","year":"2022","unstructured":"Chand G, et al. Schizophrenia imaging signatures and their associations with cognition, psychopathology, and genetics in the general population. Am J Psychiatry. 2022;179(9):650\u201360.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"6905_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1176\/appi.ajp.2009.09050716","volume":"167","author":"R P\u00e9rez-Iglesias","year":"2010","unstructured":"P\u00e9rez-Iglesias R, et al. White matter integrity and cognitive impairment in First-Episode psychosis. Am J Psychiatry. 2010;167(4):451\u20138.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"6905_CR6","doi-asserted-by":"publisher","first-page":"b3016","DOI":"10.1136\/bmj.b3016","volume":"339","author":"Z Morris","year":"2009","unstructured":"Morris Z, et al. Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2009;339(1):b3016.","journal-title":"BMJ"},{"key":"6905_CR7","doi-asserted-by":"publisher","first-page":"118089","DOI":"10.1016\/j.neuroimage.2021.118089","volume":"236","author":"R Crockett","year":"2021","unstructured":"Crockett R, et al. Painting by lesions: white matter hyperintensities disrupt functional networks and global cognition. NeuroImage. 2021;236:118089.","journal-title":"NeuroImage"},{"issue":"2","key":"6905_CR8","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1148\/radiol.2021202634","volume":"298","author":"LWM Vergoossen","year":"2021","unstructured":"Vergoossen LWM, et al. Interplay of white matter hyperintensities, cerebral networks, and cognitive function in an adult population: Diffusion-Tensor imaging in the Maastricht study. Radiology. 2021;298(2):384\u201392.","journal-title":"Radiology"},{"issue":"12","key":"6905_CR9","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/mp.2016.3","volume":"21","author":"DR Goldsmith","year":"2016","unstructured":"Goldsmith DR, et al. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 2016;21(12):1696\u2013709.","journal-title":"Mol Psychiatry"},{"key":"6905_CR10","doi-asserted-by":"crossref","unstructured":"Wang S et al. Establishment of an assistive diagnostic model for schizophrenia with oxidative stress biomarkers. 2023;14:1158254.","DOI":"10.3389\/fphar.2023.1158254"},{"key":"6905_CR11","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.physbeh.2014.02.032","volume":"129","author":"E Asevedo","year":"2014","unstructured":"Asevedo E, et al. Peripheral interleukin-2 level is associated with negative symptoms and cognitive performance in schizophrenia. Physiol Behav. 2014;129:194\u20138.","journal-title":"Physiol Behav"},{"issue":"5","key":"6905_CR12","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1001\/jamapsychiatry.2022.0407","volume":"79","author":"J Williams","year":"2022","unstructured":"Williams J, et al. Inflammation and brain structure in schizophrenia and other neuropsychiatric disorders: A Mendelian randomization study. JAMA Psychiatry. 2022;79(5):498\u2013507.","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"6905_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/acps.13416","volume":"146","author":"C Dunleavy","year":"2022","unstructured":"Dunleavy C, et al. Inflammation in first-episode psychosis: the contribution of inflammatory biomarkers to the emergence of negative symptoms, a systematic review and meta-analysis. Acta Psychiatrica Scandinavica. 2022;146(1):6\u201320.","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"4","key":"6905_CR14","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1136\/svn-2021-001102","volume":"7","author":"D Zhang","year":"2022","unstructured":"Zhang D, et al. Inflammatory biomarkers and cerebral small vessel disease: a community-based cohort study. Stroke Vascular Neurol. 2022;7(4):302\u20139.","journal-title":"Stroke Vascular Neurol"},{"key":"6905_CR15","doi-asserted-by":"publisher","first-page":"100916","DOI":"10.1016\/j.arr.2019.100916","volume":"53","author":"A Low","year":"2019","unstructured":"Low A, et al. Inflammation and cerebral small vessel disease: A systematic review. Ageing Res Rev. 2019;53:100916.","journal-title":"Ageing Res Rev"},{"key":"6905_CR16","doi-asserted-by":"crossref","unstructured":"Altendahl M et al. An IL-18-centered inflammatory network as a biomarker for cerebral white matter injury. PLoS ONE. 2020;15(1):e0227835.","DOI":"10.1371\/journal.pone.0227835"},{"key":"6905_CR17","doi-asserted-by":"crossref","unstructured":"Audrey L et al. Inflammation and cerebral small vessel disease: A systematic review. Ageing Res Rev. 2019;53(0).","DOI":"10.1016\/j.arr.2019.100916"},{"key":"6905_CR18","doi-asserted-by":"crossref","unstructured":"David F et al. Oxidative stress and inflammation in early onset first episode psychosis: A systematic review and Meta-Analysis. Int J Neuropsychopharmacol. 2017;20(6).","DOI":"10.1093\/ijnp\/pyx015"},{"issue":"12","key":"6905_CR19","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1161\/STROKEAHA.113.002813","volume":"44","author":"N Miyamoto","year":"2013","unstructured":"Miyamoto N, et al. Oxidative stress interferes with white matter renewal after prolonged cerebral hypoperfusion in mice. Stroke. 2013;44(12):3516\u201321.","journal-title":"Stroke"},{"issue":"1","key":"6905_CR20","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12974-022-02468-0","volume":"19","author":"L Jiang","year":"2022","unstructured":"Jiang L, et al. Association of inflammatory markers with cerebral small vessel disease in community-based population. J Neuroinflamm. 2022;19(1):106.","journal-title":"J Neuroinflamm"},{"key":"6905_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.neurobiolaging.2017.06.029","volume":"59","author":"W Swardfager","year":"2017","unstructured":"Swardfager W, et al. Peripheral lipid oxidative stress markers are related to vascular risk factors and subcortical small vessel disease. Neurobiol Aging. 2017;59:91\u20137.","journal-title":"Neurobiol Aging"},{"issue":"12","key":"6905_CR22","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1161\/STROKEAHA.123.044297","volume":"54","author":"F de Kort","year":"2023","unstructured":"de Kort F, et al. White matter hyperintensity volume and poststroke cognition: an individual patient data pooled analysis of 9 ischemic stroke cohort studies. Stroke. 2023;54(12):3021\u20139.","journal-title":"Stroke"},{"key":"6905_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neubiorev.2020.11.007","volume":"120","author":"H Hu","year":"2021","unstructured":"Hu H, et al. White matter hyperintensities and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 36 prospective studies. Neurosci Biobehav Rev. 2021;120:16\u201327.","journal-title":"Neurosci Biobehav Rev"},{"key":"6905_CR24","doi-asserted-by":"crossref","unstructured":"Ming-Liang W et al. Prevalence of white matter hyperintensity in young clinical patients. AJR Am J Roentgenol. 2019;213(3).","DOI":"10.2214\/AJR.18.20888"},{"key":"6905_CR25","first-page":"22","volume":"23","author":"F Patrizia","year":"2022","unstructured":"Patrizia F, et al. Association of LTA and SOD gene polymorphisms with cerebral white matter hyperintensities in migraine patients. Int J Mol Sci. 2022;23:22.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"6905_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nrneurol.2015.10","volume":"11","author":"ND Prins","year":"2015","unstructured":"Prins ND, Scheltens P. White matter hyperintensities, cognitive impairment and dementia: an update. Nat Reviews Neurol. 2015;11(3):157\u201365.","journal-title":"Nat Reviews Neurol"},{"key":"6905_CR27","doi-asserted-by":"crossref","unstructured":"Dan Y et al. Connectome gradient dysfunction contributes to white matter hyperintensity-related cognitive decline. CNS Neurosci Ther. 2024;30(7).","DOI":"10.1111\/cns.14843"},{"key":"6905_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.neuroscience.2020.08.037","volume":"449","author":"J Du","year":"2020","unstructured":"Du J, et al. Structural brain network disruption at preclinical stage of cognitive impairment due to cerebral small vessel disease. Neuroscience. 2020;449:99\u2013115.","journal-title":"Neuroscience"},{"key":"6905_CR29","doi-asserted-by":"crossref","unstructured":"Biesbroek J et al. Lesion location and cognitive impact of cerebral small vessel disease. 2017;131(8):715\u201328.","DOI":"10.1042\/CS20160452"},{"key":"6905_CR30","doi-asserted-by":"crossref","unstructured":"Biesbroek J et al. Impact of strategically located white matter hyperintensities on cognition in memory clinic patients with small vessel disease. 2016;11(11):e0166261.","DOI":"10.1371\/journal.pone.0166261"},{"key":"6905_CR31","doi-asserted-by":"crossref","unstructured":"Pol JG et al. Effects of interleukin-2 in immunostimulation and immunosuppression. J Exp Med. 2020;217(1).","DOI":"10.1084\/jem.20191247"},{"key":"6905_CR32","doi-asserted-by":"crossref","unstructured":"Kadhim H et al. Interleukin-2 in the pathogenesis of perinatal white matter damage. 2002;58(7):1125\u20138.","DOI":"10.1212\/WNL.58.7.1125"},{"issue":"11","key":"6905_CR33","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1177\/0271678X211028680","volume":"41","author":"H Pu","year":"2021","unstructured":"Pu H, et al. Intranasal delivery of interleukin-4 attenuates chronic cognitive deficits via beneficial microglial responses in experimental traumatic brain injury. J Cereb Blood Flow Metabolism. 2021;41(11):2870\u201386.","journal-title":"J Cereb Blood Flow Metabolism"},{"issue":"11","key":"6905_CR34","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.3390\/ijms20112812","volume":"20","author":"V Cipollini","year":"2019","unstructured":"Cipollini V, et al. Emerging biomarkers in vascular cognitive impairment and dementia: from pathophysiological pathways to clinical application. Int J Mol Sci. 2019;20(11):2812.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"6905_CR35","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1161\/STROKEAHA.118.023192","volume":"49","author":"M Noz","year":"2018","unstructured":"Noz M, et al. Trained immunity characteristics are associated with progressive cerebral small vessel disease. Stroke. 2018;49(12):2910\u20137.","journal-title":"Stroke"},{"key":"6905_CR36","doi-asserted-by":"crossref","unstructured":"C L, S., et al. Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3\u00a0C-Dijon Study. Neurology. 2012;78(10).","DOI":"10.1212\/WNL.0b013e318248e50f"},{"key":"6905_CR37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/STROKEAHA.107.496554","volume":"39","author":"F Myriam","year":"2008","unstructured":"Myriam F, et al. Biomarkers of inflammation and MRI-Defined small vessel disease of the brain: the cardiovascular health study. Stroke. 2008;39:7.","journal-title":"Stroke"},{"key":"6905_CR38","first-page":"0","volume":"14","author":"A-C Eric Alonso","year":"2023","unstructured":"Eric Alonso A-C, et al. Modulation of vagal activity May help reduce neurodevelopmental damage in the offspring of mothers with pre-eclampsia. Front Immunol. 2023;14:0.","journal-title":"Front Immunol"},{"key":"6905_CR39","doi-asserted-by":"crossref","unstructured":"Masaaki O et al. IFN-\u03b3-induced Th1-Treg polarization in inflamed brains limits exacerbation of experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA. 2024;121(48).","DOI":"10.1073\/pnas.2401692121"},{"key":"6905_CR40","doi-asserted-by":"crossref","unstructured":"Sosa RA et al. IFN-\u03b3 ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation. Proceedings of the National Academy of Sciences. 2015;112(36):E5038\u2013E5047.","DOI":"10.1073\/pnas.1505955112"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-06905-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-025-06905-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-025-06905-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T09:47:17Z","timestamp":1746611237000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-025-06905-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6905"],"URL":"https:\/\/doi.org\/10.1186\/s12888-025-06905-1","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"assertion":[{"value":"10 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of the First Affiliated Hospital of Zhengzhou University (Approval No. 2019-KY-0271) provided full ethical approval for this study, and written informed consent was obtained from all study participants before investigation. All studies were conducted in accordance with the Declaration of Helsinki, the Data Protection Act and other relevant guidelines and regulations. Written informed consent was obtained from all study participants and their parents or legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The manuscript contains any information\/images that the participant agrees to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"462"}}